Global trials Myonex operates with a global footprint across the US, Germany, UK, and France, offering a scalable, integrated clinical trial supply and pharmaceutical services platform. This presents up-selling opportunities to multinational sponsors seeking consistent cross-border execution and centralized project management.

New capabilities Recent launch of CTRx and the establishment of a new 65,000 sq ft global headquarters signal a strategic push into patient card programs, centralized dispensing, and local drug supply for trials. This creates cross-sell potential to sponsors needing streamlined patient access and on-demand pharmaceutical sourcing.

Acquisitions acquisitions including Creapharm and SaveWay expand service breadth in pharmaceutical services and US clinical trial support. This enhances Myonex’s end-to-end capabilities and opens doors to sponsors looking for integrated platforms with multiple service lines.

Leadership expansion Recent leadership additions including a new CEO and COO with industry pedigree indicate a growth-focused strategy and potential for formalized enterprise sales motions, geographic expansion, and larger-scale deals with pharma and CROs.

Technology stack Use of Salesforce, SAP, Oracle Cloud, and DocuSign points to a modern, enterprise-grade tech backbone for order management, ERP, and contract execution. This alignment supports selling to mid-to-large pharma accounts that require robust integration and secure, efficient trial operations.